US 9676858
Human bispecific EGFRvIII antibody and CD3 engaging molecules
granted A61KA61K2039/505A61P
Quick answer
US patent 9676858 (Human bispecific EGFRvIII antibody and CD3 engaging molecules) held by The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary Department of Health and Human Services (NIH)
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00